{"count": 568, "results": [{"_id": "35269852", "pmid": 35269852, "pmcid": "PMC8910543", "title": "Metformin and Breast Cancer: Where Are We Now?", "journal": "Int J Mol Sci", "authors": ["Cejuela M", "Martin-Castillo B", "Menendez JA", "Pernas S"], "date": "2022-02-28T00:00:00Z", "doi": "10.3390/ijms23052705", "meta_date_publication": "2022 Feb 28", "meta_volume": "23", "meta_issue": "5", "meta_pages": "", "score": 50273.055, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@Breast Cancer@@@: Where Are We Now?", "citations": {"NLM": "Cejuela M, Martin-Castillo B, Menendez JA, Pernas S. Metformin and Breast Cancer: Where Are We Now? Int J Mol Sci. 2022 Feb 28;23(5):. PMID: 35269852", "BibTeX": "@article{35269852, title={Metformin and Breast Cancer: Where Are We Now?}, author={Cejuela M and Martin-Castillo B and Menendez JA and Pernas S}, journal={Int J Mol Sci}, volume={23}, number={5}}"}}, {"_id": "36766896", "pmid": 36766896, "pmcid": "PMC9914021", "title": "Metformin Therapy and Breast Cancer Incidence in the Ha'il Region", "journal": "Healthcare (Basel)", "authors": ["Osman M", "Muqbel T", "Abduallh A", "Alanazi S", "Khalifa NE", "Khojali WMA", "Elagib HM", "Hussein W", "Abdallah MH"], "date": "2023-01-20T00:00:00Z", "doi": "10.3390/healthcare11030321", "meta_date_publication": "2023 Jan 20", "meta_volume": "11", "meta_issue": "3", "meta_pages": "", "score": 50269.383, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ Therapy and @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@Breast Cancer@@@ Incidence in the Ha'il Region", "citations": {"NLM": "Osman M, Muqbel T, Abduallh A, Alanazi S, Khalifa NE, Khojali WMA, Elagib HM, Hussein W, Abdallah MH. Metformin Therapy and Breast Cancer Incidence in the Ha'il Region Healthcare (Basel). 2023 Jan 20;11(3):. PMID: 36766896", "BibTeX": "@article{36766896, title={Metformin Therapy and Breast Cancer Incidence in the Ha'il Region}, author={Osman M and Muqbel T and Abduallh A and Alanazi S and Khalifa NE and Khojali WMA and Elagib HM and Hussein W and Abdallah MH}, journal={Healthcare (Basel)}, volume={11}, number={3}}"}}, {"_id": "35538143", "pmid": 35538143, "pmcid": "PMC9091204", "title": "The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial", "journal": "Sci Rep", "authors": ["Barakat HE", "Hussein RRS", "Elberry AA", "Zaki MA", "Ramadan ME"], "date": "2022-05-10T00:00:00Z", "doi": "10.1038/s41598-022-11138-3", "meta_date_publication": "2022 May 10", "meta_volume": "12", "meta_issue": "1", "meta_pages": "7656", "score": 50269.31, "text_hl": "Recently, several clinical trials have attempted to find evidence that supports the anticancer use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@ (@<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@BC@@@) @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Barakat HE, Hussein RRS, Elberry AA, Zaki MA, Ramadan ME. The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial Sci Rep. 2022 May 10;12(1):7656. PMID: 35538143", "BibTeX": "@article{35538143, title={The impact of metformin use on the outcomes of locally advanced breast cancer patients receiving neoadjuvant chemotherapy: an open-labelled randomized controlled trial}, author={Barakat HE and Hussein RRS and Elberry AA and Zaki MA and Ramadan ME}, journal={Sci Rep}, volume={12}, number={1}, pages={7656}}"}}, {"_id": "36562831", "pmid": 36562831, "pmcid": "PMC9879830", "title": "Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study", "journal": "Eur J Clin Pharmacol", "authors": ["El-Attar AA", "Ibrahim OM", "Alhassanin SA", "Essa ES", "Mostafa TM"], "date": "2023-02-01T00:00:00Z", "doi": "10.1007/s00228-022-03444-6", "meta_date_publication": "2023 Feb", "meta_volume": "79", "meta_issue": "2", "meta_pages": "299-309", "score": 50268.168, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ might represent a safe and promising adjuvant therapy to @CHEMICAL_Letrozole @CHEMICAL_MESH:D000077289 @@@letrozole@@@ in @DISEASE_Overweight @DISEASE_MESH:D050177 @@@overweight@@@/@DISEASE_Obesity @DISEASE_MESH:D009765 @@@obese@@@ postmenopausal @SPECIES_9606 @@@women@@@ with @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@.", "citations": {"NLM": "El-Attar AA, Ibrahim OM, Alhassanin SA, Essa ES, Mostafa TM. Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study Eur J Clin Pharmacol. 2023 Feb;79(2):299-309. PMID: 36562831", "BibTeX": "@article{36562831, title={Effect of metformin as an adjuvant therapy to letrozole on estradiol and other biomarkers involved in the pathogenesis of breast cancer in overweight and obese postmenopausal women: a pilot study}, author={El-Attar AA and Ibrahim OM and Alhassanin SA and Essa ES and Mostafa TM}, journal={Eur J Clin Pharmacol}, volume={79}, number={2}, pages={299-309}}"}}, {"_id": "34408607", "pmid": 34408607, "pmcid": "PMC8348326", "title": "Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial", "journal": "J Taibah Univ Med Sci", "authors": ["Rizvi F", "Shaukat L", "Azhar A", "Jafri A", "Aslam U", "Imran-Ul-Haq H"], "date": "2021-03-17T00:00:00Z", "doi": "10.1016/j.jtumed.2021.02.006", "meta_date_publication": "2021 Aug", "meta_volume": "16", "meta_issue": "4", "meta_pages": "504-512", "score": 50267.7, "text_hl": "Preclinical meritorious anticancer effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ against @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@: An In vivo trial", "citations": {"NLM": "Rizvi F, Shaukat L, Azhar A, Jafri A, Aslam U, Imran-Ul-Haq H. Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial J Taibah Univ Med Sci. 2021 Aug;16(4):504-512. PMID: 34408607", "BibTeX": "@article{34408607, title={Preclinical meritorious anticancer effects of Metformin against breast cancer: An In vivo trial}, author={Rizvi F and Shaukat L and Azhar A and Jafri A and Aslam U and Imran-Ul-Haq H}, journal={J Taibah Univ Med Sci}, volume={16}, number={4}, pages={504-512}}"}}, {"_id": "32883003", "pmid": 32883003, "pmcid": "PMC7565921", "title": "Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells", "journal": "Cancers (Basel)", "authors": ["Samuel SM", "Varghese E", "Koklesová L", "Líšková A", "Kubatka P", "Büsselberg D"], "date": "2020-09-01T00:00:00Z", "doi": "10.3390/cancers12092482", "meta_date_publication": "2020 Sep 1", "meta_volume": "12", "meta_issue": "9", "meta_pages": "", "score": 50266.332, "text_hl": "Counteracting Chemoresistance with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@Breast Cancers@@@: Targeting @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@Cancer@@@ Stem Cells", "citations": {"NLM": "Samuel SM, Varghese E, Koklesová L, Líšková A, Kubatka P, Büsselberg D. Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells Cancers (Basel). 2020 Sep 1;12(9):. PMID: 32883003", "BibTeX": "@article{32883003, title={Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells}, author={Samuel SM and Varghese E and Koklesová L and Líšková A and Kubatka P and Büsselberg D}, journal={Cancers (Basel)}, volume={12}, number={9}}"}}, {"_id": "31819193", "pmid": 31819193, "pmcid": "PMC6986920", "title": "Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin", "journal": "Br J Cancer", "authors": ["Lord SR", "Collins JM", "Cheng WC", "Haider S", "Wigfield S", "Gaude E", "Fielding BA", "Pinnick KE", "Harjes U", "Segaran A", "Jha P", "Hoefler G", "Pollak MN", "Thompson AM", "Roy PG", "English R", "Adams RF", "Frezza C", "Buffa FM", "Karpe F", "Harris AL"], "date": "2020-01-01T00:00:00Z", "doi": "10.1038/s41416-019-0665-5", "meta_date_publication": "2020 Jan", "meta_volume": "122", "meta_issue": "2", "meta_pages": "258-265", "score": 50265.816, "text_hl": "However, in our cell line models of @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ inhibited FAO. ", "citations": {"NLM": "Lord SR, Collins JM, Cheng WC, Haider S, Wigfield S, Gaude E, Fielding BA, Pinnick KE, Harjes U, Segaran A, Jha P, Hoefler G, Pollak MN, Thompson AM, Roy PG, English R, Adams RF, Frezza C, Buffa FM, Karpe F, Harris AL. Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin Br J Cancer. 2020 Jan;122(2):258-265. PMID: 31819193", "BibTeX": "@article{31819193, title={Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin}, author={Lord SR and Collins JM and Cheng WC and Haider S and Wigfield S and Gaude E and Fielding BA and Pinnick KE and Harjes U and Segaran A and Jha P and Hoefler G and Pollak MN and Thompson AM and Roy PG and English R and Adams RF and Frezza C and Buffa FM and Karpe F and Harris AL}, journal={Br J Cancer}, volume={122}, number={2}, pages={258-265}}"}}, {"_id": "36233373", "pmid": 36233373, "pmcid": "PMC9572354", "title": "Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment", "journal": "J Clin Med", "authors": ["Essa NM", "Salem HF", "Elgendy MO", "Gabr A", "Omran MM", "Hassan NA", "Tashkandi HM", "Harakeh S", "Boshra MS"], "date": "2022-09-20T00:00:00Z", "doi": "10.3390/jcm11195505", "meta_date_publication": "2022 Sep 20", "meta_volume": "11", "meta_issue": "19", "meta_pages": "", "score": 50265.13, "text_hl": "Efficacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ as Adjuvant Therapy in Metastatic @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@Breast Cancer@@@ Treatment", "citations": {"NLM": "Essa NM, Salem HF, Elgendy MO, Gabr A, Omran MM, Hassan NA, Tashkandi HM, Harakeh S, Boshra MS. Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment J Clin Med. 2022 Sep 20;11(19):. PMID: 36233373", "BibTeX": "@article{36233373, title={Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment}, author={Essa NM and Salem HF and Elgendy MO and Gabr A and Omran MM and Hassan NA and Tashkandi HM and Harakeh S and Boshra MS}, journal={J Clin Med}, volume={11}, number={19}}"}}, {"_id": "35852878", "pmid": 35852878, "pmcid": "PMC9365564", "title": "Metformin and breast cancer: an opportunity for pharmacogenetics", "journal": "Aging (Albany NY)", "authors": ["Cuyàs E", "Martin-Castillo B", "Menendez JA"], "date": "2022-07-18T00:00:00Z", "doi": "10.18632/aging.204180", "meta_date_publication": "2022 Jul 18", "meta_volume": "14", "meta_issue": "14", "meta_pages": "5612-5613", "score": 50264.867, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ and @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@: an opportunity for pharmacogenetics", "citations": {"NLM": "Cuyàs E, Martin-Castillo B, Menendez JA. Metformin and breast cancer: an opportunity for pharmacogenetics Aging (Albany NY). 2022 Jul 18;14(14):5612-5613. PMID: 35852878", "BibTeX": "@article{35852878, title={Metformin and breast cancer: an opportunity for pharmacogenetics}, author={Cuyàs E and Martin-Castillo B and Menendez JA}, journal={Aging (Albany NY)}, volume={14}, number={14}, pages={5612-5613}}"}}, {"_id": "38057926", "pmid": 38057926, "pmcid": "PMC10699048", "title": "Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis", "journal": "Diabetol Metab Syndr", "authors": ["Chen Y", "Bai B", "Ye S", "Gao X", "Zheng X", "Ying K", "Pan H", "Xie B"], "date": "2023-12-06T00:00:00Z", "doi": "10.1186/s13098-023-01218-3", "meta_date_publication": "2023 Dec 6", "meta_volume": "15", "meta_issue": "1", "meta_pages": "252", "score": 50264.324, "text_hl": "Literature review of clinical studies concerning @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use on @<m>DISEASE_Breast_Neoplasms</m> @DISEASE_MESH:D001943 @@@breast cancer@@@", "citations": {"NLM": "Chen Y, Bai B, Ye S, Gao X, Zheng X, Ying K, Pan H, Xie B. Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis Diabetol Metab Syndr. 2023 Dec 6;15(1):252. PMID: 38057926", "BibTeX": "@article{38057926, title={Genetic effect of metformin use on risk of cancers: evidence from Mendelian randomization analysis}, author={Chen Y and Bai B and Ye S and Gao X and Zheng X and Ying K and Pan H and Xie B}, journal={Diabetol Metab Syndr}, volume={15}, number={1}, pages={252}}"}}]}